| Quarterly Results of Ranbaxy Laboratories (in Rs. Cr.) |
Dec '14 |
Sep '14 |
Jun '14 |
Mar '14 |
Dec '13 |
|
| Net Sales/Income from operations |
956.52 |
1,272.69 |
2,116.98 |
1,224.59 |
1,327.64 |
|
| Other Operating Income |
53.33 |
46.23 |
61.65 |
27.43 |
38.93 |
|
| Total Income From Operations |
1,009.85 |
1,318.91 |
2,178.63 |
1,252.02 |
1,366.56 |
|
| EXPENDITURE |
|
|
|
|
|
|
| Consumption of Raw Materials |
314.13 |
335.94 |
280.73 |
394.87 |
432.75 |
|
| Purchase of Traded Goods |
228.86 |
227.01 |
184.27 |
224.77 |
219.36 |
|
| Increase/Decrease in Stocks |
46.07 |
101.17 |
102.74 |
3.29 |
-82.70 |
|
| Power & Fuel |
-- |
-- |
-- |
-- |
-- |
|
| Employees Cost |
271.89 |
279.67 |
254.74 |
226.27 |
271.91 |
|
| depreciat |
54.81 |
60.15 |
65.65 |
49.98 |
45.85 |
|
| Excise Duty |
-- |
-- |
-- |
-- |
-- |
|
| Admin. And Selling Expenses |
-- |
-- |
-- |
-- |
-- |
|
| R & D Expenses |
-- |
-- |
-- |
-- |
-- |
|
| Provisions And Contingencies |
-- |
-- |
-- |
-- |
-- |
|
| Exp. Capitalised |
-- |
-- |
-- |
-- |
-- |
|
| Other Expenses |
500.41 |
530.80 |
429.76 |
440.48 |
591.29 |
|
| P/L Before Other Inc. , Int., Excpt. Items & Tax |
-406.32 |
-215.82 |
860.74 |
-87.64 |
-111.90 |
|
| Other Income |
17.75 |
20.02 |
25.76 |
636.50 |
20.60 |
|
| P/L Before Int., Excpt. Items & Tax |
-388.56 |
-195.80 |
886.50 |
548.86 |
-91.30 |
|
| Interest |
149.31 |
136.82 |
141.91 |
110.85 |
118.39 |
|
| P/L Before Exceptional Items & Tax |
-537.87 |
-332.63 |
744.59 |
438.02 |
-209.69 |
|
| Exceptional Items |
-27.27 |
-35.63 |
19.77 |
490.41 |
-186.28 |
|
| P/L Before Tax |
-565.14 |
-368.26 |
764.36 |
928.43 |
-395.96 |
|
| Tax |
855.35 |
-- |
9.24 |
30.57 |
-- |
|
| P/L After Tax from Ordinary Activities |
-1,420.49 |
-368.26 |
755.12 |
897.86 |
-395.96 |
|
| Prior Year Adjustments |
-- |
-- |
-- |
-- |
-- |
|
| Extra Ordinary Items |
-- |
-- |
-- |
-- |
-- |
|
| Net Profit/(Loss) For the Period |
-1,420.49 |
-368.26 |
755.12 |
897.86 |
-395.96 |
|
| Equity Share Capital |
212.24 |
211.95 |
211.78 |
211.66 |
211.55 |
|
| Reserves Excluding Revaluation Reserves |
-- |
-- |
-- |
-- |
-- |
|
| Equity Dividend Rate (%) |
-- |
-- |
-- |
-- |
-- |
|
| EPS Before Extra Ordinary |
|
|
|
|
|
|
| Basic EPS |
-33.47 |
-8.69 |
17.83 |
21.22 |
-9.36 |
|
| Diluted EPS |
-33.47 |
-8.69 |
17.80 |
21.19 |
-9.36 |
|
| EPS After Extra Ordinary |
|
|
|
|
|
|
| Basic EPS. |
-33.47 |
-8.69 |
17.83 |
21.22 |
-9.36 |
|
| Diluted EPS. |
-33.47 |
-8.69 |
17.80 |
21.19 |
-9.36 |
|
| Public Share Holding |
|
|
|
|
|
|
| No Of Shares (Crores) |
15.63 |
14.93 |
14.49 |
14.88 |
14.80 |
|
| Share Holding (%) |
36.77 |
35.22 |
34.18 |
35.11 |
34.93 |
|
| Promoters and Promoter Group Shareholding |
|
|
|
|
|
|
| a) Pledged/Encumbered |
|
|
|
|
|
|
| - Number of shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total sh. of prom. and promoter group) |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total Share Cap. of the company) |
-- |
-- |
-- |
-- |
-- |
|
| b) Non-encumbered |
|
|
|
|
|
|
| - Number of shares (Crores). |
26.87 |
26.87 |
26.87 |
26.87 |
26.87 |
|
| - Per. of shares (as a % of the total sh. of prom. and promoter group). |
100.00 |
100.00 |
100.00 |
100.00 |
100.00 |
|
| - Per. of shares (as a % of the total Share Cap. of the company). |
63.22 |
63.37 |
63.40 |
63.41 |
63.41 |
|
Source : Dion Global Solutions Limited
